Please wait…

Login required

Username or email:

To use this function please log-in
If you haven't got an account on, you have the opportunity to register regist here for free.

add instrument

Pictet-Health P USD

Pictet-Health P USD

ISIN LU0188501257 | WKN A0B6PQ | Mnemonic PBFL | Type fund
01/01/0001 00:00
Bid Ask
This product is subject to quotation restrictions.
Change from Prev. Day 0.00 EUR / 0.00%
Spread absolute / relative 0,00 / 0,00%

Net Asset Value

Previous Day 278.32 USD Date 15/03/2019

Price Information

Last Price 0.0000
Date / Time /
Price -
Volume in euro -
Volume Size -
High 0.000
Low 0.000
52 week High 0.000
52 week Low 0.000
Trading Hours 09:00 - 18:00

Price History

Date Opening Price Closing Price Daily High Daily Low Volume (pcs.)
15/03/2019 244.7000 244.9700 244.9700 244.7000
14/03/2019 245.3000 244.9200 245.3000 244.9200
13/03/2019 242.2800 242.2800 242.2800 242.2800
12/03/2019 242.2900 242.3200 242.3200 242.2900
11/03/2019 236.9800 237.0600 237.0600 236.9800


Management Fee 1.60 %
Custodian Fee 0.02 %
Capital forming savings possible? no
Savings Plan no
Distribution Non Distributing

Frankfurt Trading Parameters

Continous Quotation no
Minimum tradeable Unit 1

Rating for Pictet-Health P USD

€uro FondsNote 4
Lipper Leaders, 3 years
Lipper Leaders, 5 years
Lipper Leaders, 10 years
Lipper Leaders, overall


Fundamental Data

ISIN LU0188501257
Name Pictet-Health P USD
Investment Company Pictet
Issued in Luxemburg
Issue Date 30/06/2004
Category Aktienfonds Pharma + Gesundheit
currency USD
Volume 81,388,075.63
Depositary Bank Pictet & Cie (Europe) S.A.
Paying Agent Deutsche Bank
Fund Management Paulina Niewiadomska, Michael Sjöström (CFA)
Fiscal Year-End 30.09.
Last Update 22/04/2017

Investment policy

invest like Pictet-Health P USD: Das Fondsmanagement strebt Kapitalwachstum an, indem es vorwiegend in Aktien oder ähnlichen Wertpapieren von Unternehmen anlegt, die im Gesundheitssektor tätig sind. Der Fondsmanager kann in alle Länder (einschließlich Schwellenländer) investieren. Als Finanzinstrumente kommen hauptsächlich internationale börsennotierte Aktien in Frage. Der Fondsmanager kann in China A-Aktien investieren, und zwar bis maximal 35 % seines Nettovermögens über das QFII-System ("Qualified Foreign Institutional Investor"), ferner über das RQFII-System ("Renminbi QFII") und/oder das Programm Shanghai-Hong Kong Stock Connect und/oder indirekt über Finanzderivate auf China A-Aktien. Der Fondsmanager kann zur effizienten Portfolioverwaltung oder zu Absicherungszwecken Finanzderivate einsetzen. Der Fondsmanager kann ferner in strukturierten Produkten anlegen.

The following Disclaimer and Information has been prepared by Voltabox AG (the “Issuer”) for the purpose of publishing THE securities prospectus by the issuer. Deutsche Boerse AG does not assume any responsibility for the content of the issuer`s Disclaimer and information.


Important Information


The information contained on the following web pages is directed only at persons who are resident of or domiciled in the Federal Republic of Germany (“Germany”) or the Grand Duchy of Luxembourg (“Luxembourg”). The following information does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for any securities. No offer of securities of the Issuer is being, or will be, made to the public outside Germany and Luxembourg. The offer in Germany and Luxembourg is being made solely on the basis of the securities prospectus (including any amendments thereto) which has been approved by the German Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and which has been published on the Issuer’s website. Any investment decision regarding the publicly offered securities of the Issuer should only be made on the basis of the securities prospectus. The securities prospectus is available free of charge from the Issuer (Artegastraße 1, 33129 Delbrück, Germany; Tel.: +49 (0)5250 9930-900; Fax: +49 (0)5250 9762-102) and on the Issuer’s website (

The information contained on the following web pages is not an offer of securities for sale or a solicitation of an offer to purchase securities in the United States of America (“United States”), Canada, Australia or Japan. The Issuer’s shares, and the securities offered in the course of the offer, have not been and will not be registered under the US Securities Act of 1933, as amended (“Securities Act”), or with any other securities regulatory authority of any state or other jurisdiction of the United States and may not be offered, sold or delivered within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws. The Issuer does not intend to register the offer or parts thereof in the United States or make an offer to the public in the United States, Canada, Australia or Japan.

The information contained on the following web pages is not for distribution to persons who are located in the United States, Canada, Australia or Japan or any other jurisdiction where the offer of the securities to the public is not taking place. Any violation of these restrictions may constitute a breach of the securities laws of these countries. The copying, forwarding or other transmission of the content of the following web pages is prohibited.

By clicking the "I AGREE" button below, you warrant that (i) you have read and accepted the foregoing information and restrictions in full and (ii) you are a resident of or domiciled in Germany or Luxembourg, and (iii) you agree not to distribute or forward the information contained on the following web pages to any person who is not a resident of or domiciled in Germany or Luxembourg.


We regret that, due to regulatory restrictions, we are unable to provide you with access to the following web pages.